Brief: Enwave Signs Material Transfer Agreement With AstraZeneca To Trial Radiant Energy Vacuum Technology For Pharmaceutical Dehydration
09/07/2021 14:13
July 9 (Reuters) - AstraZeneca PLC AZN.L :
* ENWAVE SIGNS MATERIAL TRANSFER AGREEMENT WITH ASTRAZENECA
TO
TRIAL RADIANT ENERGY VACUUM TECHNOLOGY FOR PHARMACEUTICAL
DEHYDRATION
Source text for Eikon: ID:nGNXb3T2f
Further company coverage: AZN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enwave
See all newsBrief: Enwave Signs Royalty-Bearing Commercial License With Ashland Dehydrated Foods And Sells Two 10Kw Revenue™ Machines
Canada's EnWave Q3 revenue rises on sale of machines held in inventory, higher royalties
Brief: EnWave Q3 Revenue CAD 3.313 Million
Canada's EnWave Q2 revenue falls 69% on lower machine sales
Brief: EnWave Q2 Revenue CAD 1.159 Million